CDE Includes Chiral Tech’s Cerdelga Generic in Rare Disease Care Plan
China’s Center for Drug Evaluation (CDE) announced the inclusion of Beijing Chiral Tech’s generic version...
Insight, China's Pharmaceutical Industry
Fineline Insights, Pharma Clarity